A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)

Conditions: X-Linked Retinitis Pigmentosa Interventions: Biological: rAAV2tYF-GRK1-RPGR Sponsors: Beacon Therapeutics Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials